These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6113997)

  • 21. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Clinical Efficacy and Adverse Effects of β-Blocking Agents Used Clinically for Chronic Heart Failure.
    Takayanagi R; Fujito K; Kimura K; Yamada Y
    Biol Pharm Bull; 2017; 40(6):837-843. PubMed ID: 28566627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study].
    Ertl G; Nitschmann S
    Internist (Berl); 2004 Jul; 45(7):835-6. PubMed ID: 15054581
    [No Abstract]   [Full Text] [Related]  

  • 24. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Coca SG; Buller GK
    Lancet; 2003 Sep; 362(9389):1076; author reply 1077-8. PubMed ID: 14522541
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris.
    van der Does R; Hauf-Zachariou U; Pfarr E; Holtbrügge W; König S; Griffiths M; Lahiri A
    Am J Cardiol; 1999 Mar; 83(5):643-9. PubMed ID: 10080412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is "COMET" pointing in the right direction?--Con].
    Schneider CA
    Dtsch Med Wochenschr; 2003 Dec; 128(50):2667. PubMed ID: 14673748
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction.
    Mackie IA; Seal DV; Pescod JM
    Br J Ophthalmol; 1977 May; 61(5):354-9. PubMed ID: 17431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metoprolol and alopecia.
    Graeber CW; Lapkin RA
    Cutis; 1981 Dec; 28(6):633-4. PubMed ID: 7318502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatitis as a side-effect of long-term topical treatment with certain beta-blocking agents.
    van Joost T; Middelkamp J; Ros FE
    Br J Dermatol; 1979 Aug; 101(2):171-7. PubMed ID: 39586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Beta blockers for therapy of chronic heart failure].
    Murakami T
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):248-54. PubMed ID: 15768588
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia].
    Pristautz H; Stradner F
    Wien Med Wochenschr; 1986 Sep; 136(17):443-8. PubMed ID: 2879389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative metoprolol and risk of stroke after noncardiac surgery.
    Mashour GA; Sharifpour M; Freundlich RE; Tremper KK; Shanks A; Nallamothu BK; Vlisides PE; Weightman A; Matlen L; Merte J; Kheterpal S
    Anesthesiology; 2013 Dec; 119(6):1340-6. PubMed ID: 23612244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side effects and contraindications of beta-receptor blocking agents.
    Lydtin H
    Klin Wochenschr; 1977 May; 55(9):415-22. PubMed ID: 17766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermatitis as side-effect of long-term metoprolol.
    Neumann HA; Van Joost T; Westerhof W
    Lancet; 1979 Oct; 2(8145):745. PubMed ID: 90833
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-adrenoceptor antagonist-induced psoriasiform eruption. Clinical and pathogenetic aspects.
    Heng MC; Heng MK
    Int J Dermatol; 1988 Nov; 27(9):619-27. PubMed ID: 2906634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.
    Wright RA; Perrie AM; Stenhouse F; Alberti KG; Riemersma RA; MacGregor IR; Boon NA
    Eur J Clin Pharmacol; 1994; 46(3):279-82. PubMed ID: 7915237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metoprolol (Lopressor).
    Med Lett Drugs Ther; 1978 Nov; 20(22):97-8. PubMed ID: 30035
    [No Abstract]   [Full Text] [Related]  

  • 39. Differing beta-blocking effects of carvedilol and metoprolol.
    Stoschitzky K; Koshucharova G; Zweiker R; Maier R; Watzinger N; Fruhwald FM; Klein W
    Eur J Heart Fail; 2001 Jun; 3(3):343-9. PubMed ID: 11378006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of guideline recommended beta-blocker therapy in primary prevention implantable cardioverter defibrillator patients: insight from Danish nationwide registers.
    Ruwald AC; Gislason GH; Vinther M; Johansen JB; Nielsen JC; Petersen HH; Torp-Pedersen C; Riahi S; Jøns C
    Europace; 2018 Feb; 20(2):301-307. PubMed ID: 28339659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.